Bayer and J&J settle Xarelto lawsuits in USBayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 Share XBayer and J&J settle Xarelto lawsuits in UShttps://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/
Celgene gets US patent let-off ahead of BMS mergerShares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on Share XCelgene gets US patent let-off ahead of BMS mergerhttps://pharmaphorum.com/news/celgene-gets-us-patent-let-off-ahead-of-bms-merger/
Documentaries lift lid on Theranos biotech scamAs criminal fraud investigations continue into former Theranos CEO Elizabeth Holmes and president Ramesh Balwani, further details are Share XDocumentaries lift lid on Theranos biotech scamhttps://pharmaphorum.com/news/documentaries-lift-lid-on-theranos-biotech-scam/
Court backs NHS in hepatitis C procurement row with AbbVieA court has backed NHS England in a case where US pharma giant AbbVie had alleged that its Share XCourt backs NHS in hepatitis C procurement row with AbbViehttps://pharmaphorum.com/news/court-backs-nhs-in-hepatitis-c-procurement-row-with-abbvie/
Pharma stocks fall after new drug price probe in USUS politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their Share XPharma stocks fall after new drug price probe in UShttps://pharmaphorum.com/news/pharma-stocks-fall-after-new-drug-price-probe-in-us/
J&J hits back over asbestos in talc claimsShares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had Share XJ&J hits back over asbestos in talc claimshttps://pharmaphorum.com/news/jj-hits-back-over-asbestos-in-talc-claims/
Generics firms the ‘biggest cartel in US history’ – reportUS authorities looking into price fixing in the generics industry are now investigating 16 companies and the price Share XGenerics firms the ‘biggest cartel in US history’ – reporthttps://pharmaphorum.com/news/generics-firms-the-biggest-cartel-in-us-history-report/
Akorn searches for new CEO after failed Fresenius mergerUS generics firm Akorn is searching for a new CEO in the wake of a failed merger with Share XAkorn searches for new CEO after failed Fresenius mergerhttps://pharmaphorum.com/news/akorn-searches-for-new-ceo-after-failed-fresenius-merger/
Indivior hit hard as generic Suboxone defence crumblesIndivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the Share XIndivior hit hard as generic Suboxone defence crumbleshttps://pharmaphorum.com/news/indivior-hit-hard-as-generic-suboxone-defence-crumbles/
